Publication | Closed Access

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseSystemic TreatmentRheumatic DiseasesImmunologyClinical TrialsInflammatory Rheumatic DiseaseRheumatoid Arthritis PatientsVersus PlaceboConcomitant MethotrexateImmunotherapyMedicineInflammatory ArthritisRheumatoid Arthritis